This message was sent to ##Email##
|
|
|
|
|
Lab Manager
A biosensor currently in development by researchers normally focused on air pollution could provide a way to quickly and accurately detect the COVID-19 virus in the air.
The Swiss-based research group from Empa, ETH Zurich, and Zurich University Hospital had already been working on virus and bacteria monitoring technology before the COVID-19 outbreak, but pivoted in January to focus specifically on detecting the SARS-CoV-2 virus that causes the respiratory disease.
READ MORE
CNN
The U.S. Food and Drug Administration has approved the use of the drug tucatinib, or Tukysa, in combination with chemotherapy, for the treatment of adults with advanced forms of HER2-positive breast cancer that either cannot be removed with surgery, or has spread to other parts of the body, including the brain.
"The clinical trial supporting this approval enrolled and specifically studied patients with active brain metastases in addition to the overall population enrolled, which also demonstrated benefit in this subgroup," Dr. Richard Pazdur, director of the FDA's Oncology Center of Excellence, said in a statement.
READ MORE
Technology Networks
Most breast cancers utilize the female hormone estrogen to grow, so drug-induced estrogen deprivation is used as a treatment in many patients. However, cancer will recur in one-third of these patients.
READ MORE
Forbes
In a small randomized control study, researchers in China found that HIV drug Kaletra and influenza drug Arbidol have no effect on patients with mild to moderately severe COVID-19 infections.
READ MORE
 |
|
The miniiSED® is the newest addition to the iSED® family of ESR analyzers from ALCOR Scientific. The miniiSED®is a single position, fully automated ESR analyzer that works directly from the primary EDTA tube and produces an ESR result in just 15 seconds. The miniiSED® is the ideal ESR analyzer for small laboratories, POL’s and emergency clinics.
|
|
Medical News Today
The conditions that raise the risk of COVID-19 severity are high blood pressure, diabetes, heart disease, cerebrovascular disease, respiratory conditions such as chronic obstructive pulmonary disease and conditions affecting the kidneys.
Researchers are still investigating the precise reasons and mechanisms for why these conditions make COVID-19 outcomes so much worse.
READ MORE
|
|
Dark Daily
While medical laboratories gear up for testing to detect SARS-CoV-2 — the novel coronavirus that causes the COVID-19 illness — efforts also are underway for expanded use of serological tests that can detect whether an individual’s immune systems has developed antibodies against the SARS-CoV-2 virus, as well as serological surveys that epidemiologists will use to determine the extent of the infection in whole populations.
READ MORE
European Molecular Biology Laboratory via ScienceDaily
Researchers have created the first complete description of early embryo development, accounting for every single cell in the embryo. This "virtual embryo" will help to answer how the different cell types in an organism can originate from a single egg cell.
READ MORE
Medical Device and Diagnostic Industry
The agency warned healthcare providers on Tuesday that serological tests intended to detect antibodies to SARS-CoV-2 should not be used as the sole basis to diagnose infection. FDA said it does not expect an antibody test can be shown to definitively diagnose or exclude SARS-CoV-2 infection.
READ MORE
Advertisement
American Medical Technologists
 Enhance your credentials to work in the rapidly expanding field of molecular diagnostics
|
|
Promoted by
|
|
|
|
 |
ContagionLive
Several prospective, randomized trials of hydroxychloroquine for the treatment of COVID-19 are underway. The U.S. Food and Drug Administration issued an emergency use authorization for hydroxychloroquine on March 28, 2020.
READ MORE
|
SeraSub® is a synthetic serum for use as a component in preparing standards and controls for in-vitro diagnostic tests.
Learn more
|
|
|
|
To find out how to feature your company in the ASCLS eNewsletter and other advertising opportunities, contact Andy Keith at 972-402-7707.
MORE
|
|
|
|
Fast Company
As COVID-19 cases fill emergency rooms and intensive care units across the U.S., local officials have been rushing to convert hotels, convention centers, and city parks into new hospital spaces. Amid the scramble, many physicians, architects, and healthcare consultants are already talking about how modern hospital designs could change.
READ MORE
|
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
